PE20090652A1 - Compuestos de nicotinamida sustituida y sus usos en medicamentos - Google Patents
Compuestos de nicotinamida sustituida y sus usos en medicamentosInfo
- Publication number
- PE20090652A1 PE20090652A1 PE2008001619A PE2008001619A PE20090652A1 PE 20090652 A1 PE20090652 A1 PE 20090652A1 PE 2008001619 A PE2008001619 A PE 2008001619A PE 2008001619 A PE2008001619 A PE 2008001619A PE 20090652 A1 PE20090652 A1 PE 20090652A1
- Authority
- PE
- Peru
- Prior art keywords
- nicotinamide
- phenylsulfonil
- alkyl
- compounds
- medicines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
SE REFIERE A COMPUESTOS DERIVADOS DE NICOTINAMIDA DE FORMULA (I) DONDE R1 ES ALQUILO(C1-C6), ARILO, HETEROARILO OPCIONALMENTE SUSTITUIDO, ENTRE OTROS; R2 ES H O ALQUILO(C1-C6) OPCIONALMENTE SUSTITUIDO; R3 ES CICLOALQUILO(C3-C10), ARILO, HETEROARILO OPCIONALMENTE SUSTITUIDO, ENTRE OTROS; R4, R5, R6 Y R7 SON CADA UNO H O ALQUILO(C1-C6) OPCIONALMENTE SUSTITUIDO; R8, R9 Y R10 SON CADA UNO H, F, Cl, Br, CF3, ENTRE OTROS; n ES DE 0 A 2; p Y q SON CADA UNO 0 O 1. SON COMPUESTOS PREFERIDOS: 2-(2-(FENILSULFONIL)ETILTIO)-N-(PIRIDIN-2-ILMETIL)NICOTINAMIDA, 2-(2-(FENILSULFONIL)ETILTIO)-N-(PIRIDIN-4-ILMETIL)NICOTINAMIDA, N-METIL-N-(3-METILBENCIL)-2-(2-(FENILSULFONIL)ETILTIO)NICOTINAMIDA, ENTRE OTROS. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON AGONISTAS DE LOS CANALES DE KCNQ2/3 K+ SIENDO UTILES EN EL TRATAMIENTO DEL DOLOR NEUROPATICO, EPILEPSIA, INCONTINENCIA URINARIA
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102007044277A DE102007044277A1 (de) | 2007-09-17 | 2007-09-17 | Substituierte Nicotinamid-Verbindungen und deren Verwendung in Arzneimitteln |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20090652A1 true PE20090652A1 (es) | 2009-05-28 |
Family
ID=40347805
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2008001619A PE20090652A1 (es) | 2007-09-17 | 2008-09-17 | Compuestos de nicotinamida sustituida y sus usos en medicamentos |
Country Status (24)
Country | Link |
---|---|
US (1) | US8084470B2 (es) |
EP (1) | EP2188258B1 (es) |
JP (1) | JP5539205B2 (es) |
KR (1) | KR20100068453A (es) |
CN (1) | CN101801932A (es) |
AR (1) | AR068467A1 (es) |
BR (1) | BRPI0817044A2 (es) |
CA (1) | CA2699689C (es) |
CO (1) | CO6260092A2 (es) |
CY (1) | CY1113551T1 (es) |
DE (1) | DE102007044277A1 (es) |
DK (1) | DK2188258T3 (es) |
ES (1) | ES2400407T3 (es) |
HK (1) | HK1144422A1 (es) |
HR (1) | HRP20130166T1 (es) |
IL (1) | IL204496A (es) |
MX (1) | MX2010002506A (es) |
NZ (1) | NZ583684A (es) |
PE (1) | PE20090652A1 (es) |
PL (1) | PL2188258T3 (es) |
PT (1) | PT2188258E (es) |
RU (1) | RU2489425C2 (es) |
SI (1) | SI2188258T1 (es) |
WO (1) | WO2009036938A1 (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI475020B (zh) * | 2009-03-12 | 2015-03-01 | The substituted nicotine amide as a KCNQ2 / 3 modifier | |
WO2012025236A1 (en) * | 2010-08-27 | 2012-03-01 | Grünenthal GmbH | Substituted 2-oxy-quinoline-3-carboxamides as kcnq2/3 modulators |
NZ628871A (en) * | 2010-10-20 | 2015-07-31 | Gruenenthal Chemie | Substituted 6-amino-nicotinamides as kcnq2/3 modulators |
FR2968661B1 (fr) * | 2010-12-14 | 2016-01-01 | Oreal | Procede de depigmentation des matieres keratiniques a l'aide de composes thiopyridinones |
US9775843B2 (en) | 2012-10-11 | 2017-10-03 | Grünenthal GmbH | Treatment and/or prophylaxis of TSPO mediated diseases and/or disorders |
BR112015012418A2 (pt) | 2012-11-28 | 2017-07-11 | Gruenenthal Gmbh | carboxamidas específicas como moduladores de kcnq2/3 |
US9248122B2 (en) | 2012-11-28 | 2016-02-02 | Grünenthal GmbH | Heteroquinoline-3-carboxamides as KCNQ2/3 modulators |
WO2018110669A1 (en) | 2016-12-15 | 2018-06-21 | Ono Pharmaceutical Co., Ltd. | Activator of trek (twik related k+ channels) channels |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6022884A (en) * | 1997-11-07 | 2000-02-08 | Amgen Inc. | Substituted pyridine compounds and methods of use |
GB9919588D0 (en) * | 1999-08-18 | 1999-10-20 | Hoechst Schering Agrevo Gmbh | Fungicidal compounds |
IL157313A0 (en) | 2001-02-20 | 2004-02-19 | Bristol Myers Squibb Co | Modulators of kcnq potassium channels and uses thereof |
GB0319793D0 (en) * | 2003-08-22 | 2003-09-24 | Lilly Co Eli | Pyridinylmorpholine derivatives |
-
2007
- 2007-09-17 DE DE102007044277A patent/DE102007044277A1/de not_active Withdrawn
-
2008
- 2008-09-15 PL PL08802179T patent/PL2188258T3/pl unknown
- 2008-09-15 NZ NZ583684A patent/NZ583684A/en not_active IP Right Cessation
- 2008-09-15 DK DK08802179.5T patent/DK2188258T3/da active
- 2008-09-15 BR BRPI0817044 patent/BRPI0817044A2/pt not_active IP Right Cessation
- 2008-09-15 ES ES08802179T patent/ES2400407T3/es active Active
- 2008-09-15 SI SI200830849T patent/SI2188258T1/sl unknown
- 2008-09-15 JP JP2010524410A patent/JP5539205B2/ja not_active Expired - Fee Related
- 2008-09-15 RU RU2010115184/04A patent/RU2489425C2/ru not_active IP Right Cessation
- 2008-09-15 CA CA2699689A patent/CA2699689C/en not_active Expired - Fee Related
- 2008-09-15 PT PT88021795T patent/PT2188258E/pt unknown
- 2008-09-15 EP EP08802179A patent/EP2188258B1/de active Active
- 2008-09-15 MX MX2010002506A patent/MX2010002506A/es active IP Right Grant
- 2008-09-15 CN CN200880107279A patent/CN101801932A/zh active Pending
- 2008-09-15 WO PCT/EP2008/007633 patent/WO2009036938A1/de active Application Filing
- 2008-09-15 KR KR1020107008408A patent/KR20100068453A/ko not_active Application Discontinuation
- 2008-09-17 US US12/212,369 patent/US8084470B2/en not_active Expired - Fee Related
- 2008-09-17 AR ARP080104040A patent/AR068467A1/es not_active Application Discontinuation
- 2008-09-17 PE PE2008001619A patent/PE20090652A1/es not_active Application Discontinuation
-
2010
- 2010-03-12 CO CO10029446A patent/CO6260092A2/es not_active Application Discontinuation
- 2010-03-15 IL IL204496A patent/IL204496A/en not_active IP Right Cessation
- 2010-11-18 HK HK10110728.6A patent/HK1144422A1/xx not_active IP Right Cessation
-
2013
- 2013-01-15 CY CY20131100043T patent/CY1113551T1/el unknown
- 2013-02-27 HR HRP20130166AT patent/HRP20130166T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
US20090076086A1 (en) | 2009-03-19 |
MX2010002506A (es) | 2010-03-26 |
CA2699689C (en) | 2015-03-24 |
US8084470B2 (en) | 2011-12-27 |
ES2400407T3 (es) | 2013-04-09 |
CN101801932A (zh) | 2010-08-11 |
WO2009036938A1 (de) | 2009-03-26 |
KR20100068453A (ko) | 2010-06-23 |
HK1144422A1 (en) | 2011-02-18 |
DE102007044277A1 (de) | 2009-03-19 |
EP2188258B1 (de) | 2012-11-28 |
PL2188258T3 (pl) | 2013-04-30 |
JP5539205B2 (ja) | 2014-07-02 |
SI2188258T1 (sl) | 2013-01-31 |
HRP20130166T1 (hr) | 2013-03-31 |
BRPI0817044A2 (pt) | 2015-03-24 |
EP2188258A1 (de) | 2010-05-26 |
DK2188258T3 (da) | 2013-01-14 |
IL204496A (en) | 2013-02-28 |
AU2008300945A1 (en) | 2009-03-26 |
JP2010539124A (ja) | 2010-12-16 |
AR068467A1 (es) | 2009-11-18 |
RU2010115184A (ru) | 2011-10-27 |
CO6260092A2 (es) | 2011-03-22 |
RU2489425C2 (ru) | 2013-08-10 |
CY1113551T1 (el) | 2016-06-22 |
PT2188258E (pt) | 2013-01-23 |
CA2699689A1 (en) | 2009-03-26 |
NZ583684A (en) | 2011-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20090652A1 (es) | Compuestos de nicotinamida sustituida y sus usos en medicamentos | |
PE20120780A1 (es) | Nicotinamida sustituida como moduladores kcnq2/3 | |
PE20120790A1 (es) | 2-mercaptoquinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3 | |
PE20110285A1 (es) | Derivados de sulfonamidofenil propionamida como ligandos del receptor vaniloide del subtipo 1 | |
PE20060241A1 (es) | 2-quinolil-oxazoles sustituidos como inhibidores de pde4 | |
HRP20170638T1 (hr) | MODULATORI RETINOIDNIMA SRODNOG SIROČETA RECEPTORA γ (ROR-γ), NAMIJENJENI UPOTREBI U LIJEČENJU AUTOIMUNIH I PROTUUPALNIH BOLESTI | |
PE20170004A1 (es) | Inhibidores de biaril cinasa | |
PE20121058A1 (es) | Compuestos que modulan el receptor de androgenos | |
PE20140011A1 (es) | Compuestos y composiciones novedosos para la inhibicion de nampt | |
PE20141375A1 (es) | Activadores de glucoquinasa | |
PE20071245A1 (es) | COMPUESTOS INDOL SULFONAMIDA COMO MODULADORES DEL RECEPTOR DE PROGESTERONA SELECTIVOS (SPRMs) | |
PE20091005A1 (es) | N-(2-(hetaril)aril)arilsulfonamidas y n-(2-(hetaril)hetaril)arilsulfonamidas | |
PE20061124A1 (es) | Compuestos y derivados de dibencil amina | |
PE20061150A1 (es) | Derivados de n-(n-sulfonilaminoarilmetil)ciclopropanocarboxamida sustituidos como antagonistas del receptor vainilloide tipo 1 (vdr1) | |
PE20070112A1 (es) | Mimeticos de glucocorticoides, metodos para su fabricacion, composiciones farmaceuticas y usos de los mismos | |
AR070828A1 (es) | Derivados de azetidina y ciclobutano como inhibidores de jak | |
PE20091974A1 (es) | Derivados de indazoles sustituidos con fenil o piridinilo | |
PE20090622A1 (es) | Nuevos derivados de bencimidazol sustituido | |
PE20090435A1 (es) | Inhibidores de tetrahidropiranocromeno de gamma secretasa | |
PE20061353A1 (es) | Compuestos de sulfonamida-tiazolopiridina como activadores de glucocinasa | |
PE20121509A1 (es) | Compuestos de triazolopiridinas como inhibidores de quinasa mps-1 | |
PE20110063A1 (es) | DERIVADOS DE [1, 2, 4]TRIAZOLO[1, 5-a]PIRIDINA COMO INHIBIDORES DE JAK | |
CO5560563A2 (es) | Compuestos derivados de benzamida de formula iif que afectan la glucocinasa | |
PE20141702A1 (es) | Compuestos de carbamato y preparacion y uso de los mismos | |
PE20091466A1 (es) | Derivados de 4,5-dihidro-oxazol-2-il-amina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |